MARINAZZO, ELISA

MARINAZZO, ELISA  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 2009 A. Picu; E. Marinazzo; F. Prodam; F. Broglio; S. Belcastro; G. Amaretti; R. Giordano; E. Ghigo; E. Arvat
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 2010 R. Berardelli; I. Karamouzis; E. Marinazzo; E. Prats; A. Picu; R. Giordano; E. Ghigo; E. Arvat
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 2009 R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY 2008 A. Picu; R. Giordano; L. Bonelli; E. Marinazzo; R. Berardelli; M. Balbo; E. Ghigo; E. Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 2011 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
Growth hormone treatment in human ageing: benefits and risks 2008 GIORDANO R; BONELLI L; MARINAZZO E; GHIGO E; ARVAT E.
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 2007 R. Giordano ; R. Berardelli; L. Bonelli; M. Balbo; E. Marinazzo; E. Ghigo; E. Arvat
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 2008 R. GIORDANO; A. PICU; L. BONELLI; M. BALBO; R. BERARDELLI; E. MARINAZZO; G. CORNELI; E. GHIGO; E. ARVAT
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 2016 Giordano, R; Guaraldi, F; Marinazzo, E; Fumarola, F; Rampino, A; Berardelli, R; Karamouzis, I; Lucchiari, M; Manetta, T; Mengozzi, G; Arvat, E; Ghigo, E
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS 2009 E. Marinazzo; R. Berardelli; A. Picu; G. Peraga; E. Ghigo; E. Arvat; R. Giordano
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 2010 R. Giordano; E. Marinazzo; R. Berardelli; A. Picu; M. Maccario; E. Ghigo; E. Arvat.
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 2011 R. Giordano; A. Picu; E. Marinazzo; V. D'Angelo; R. Berardelli; I. Karamouzis; D.Forno; D. Zinnà; M. Maccario; E. Ghigo; E. Arvat
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 2009 Giordano R; Marzotti S; Balbo M; Romagnoli S; Marinazzo E; Berardelli R; Migliaretti G; Benso A; Falorni A; Ghigo E; Arvat E
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 2009 R. Giordano; S. Marzotti; M. Balbo; S. Romagnoli; R. Berardelli; E. Marinazzo; A. Falorni; E. Ghigo; E. Arvat
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 2010 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 2013 Karamouzis I; Berardelli R; Marinazzo E; D'Angelo V; Zinnà D; Minetto MA; Zichi C; Fussotto B; Giordano R; Ghigo E; Arvat E
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 2010 R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; R. Giordano; E. Ghigo; E. Arvat